Clinical Trial Update: Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 study evaluating PD-L1 positive non-small cell lung cancer treated with immunotherapy as monotherapy and in combinati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Squamous Cell Carcinoma of the Lung

Snippet

Sponsor: Arcus Biosciences, Inc. | Conditions: Non Small Cell Lung Cancer, Nonsquamous Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED